The Spine Phenome Project: Enabling Technology for Personalized Medicine

脊柱表型组项目:个性化医疗的支持技术

基本信息

  • 批准号:
    10375971
  • 负责人:
  • 金额:
    $ 307.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-26 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Chronic Low Back Pain (cLBP) is a debilitating condition that affects millions of people globally. Despite increased utilization of interventions and rising medical costs, cLBP prevalence has continued to increase. This problem arises because cLBP is complex, heterogeneous and current diagnostics and treatments rely primarily on subjective metrics and do not target all the multidimensional biopsychosocial mechanisms associated with cLBP. Specifically, most diagnostics do not quantitively consider patient functional measures. This multidisciplinary effort proposes to address this problem by developing and validating a digital health platform and provide meaningful data-driven metrics that enable an integrated approach to clinical evaluation and treatment of cLBP. This platform will facilitate the use of quantitative spinal motion metrics (function), PROs and patient preference information to enable deep patient phenotyping and inform clinical decision-making on personalized treatments in order to improve outcomes. This effort will involve software and hardware development to enable data collection, analysis and visualization in clinical settings. Technology development effort will be done in partnership with Switchbox Inc. (Software Strategy) and Priority Designs Inc. (Regulatory Strategy). The specific aims for UH2 phase are to: 1) Develop a Digital health platform for collecting, analyzing, and reporting core cLBP metrics; 2) Conduct a feasibility study to test the clinical operability, usability and utility of the prototype; and the specific Aims for UH3 phase are to: 1) Optimize Digital Health Platform for translation to clinical research use through BACPAC; 2) Validate the utility of the Digital Health Platform to identify cLBP patient phenotypes and inform clinical decision-making on optimal treatment pathways for individual patients. The outcome of this project will be a digital health platform with data to support regulatory submission for clinical use. At the end of this effort, we will have a validated tool for integration in clinical research studies supported by the BACPAC consortium.
项目总结/摘要 慢性腰痛(cLBP)是一种使人衰弱的疾病,影响着全球数百万人。尽管 随着干预措施的使用增加和医疗费用的上升,cLBP患病率继续增加。这 由于cLBP是复杂的、异质的,并且目前的诊断和治疗主要依赖于 主观指标,并不针对所有的多维生物心理社会机制, cLBP。具体地,大多数诊断不定量地考虑患者功能测量。这 多学科的努力提出通过开发和验证数字健康平台来解决这个问题 并提供有意义的数据驱动指标,使临床评价的综合方法成为可能, 治疗cLBP该平台将有助于使用定量脊柱运动指标(功能)、PRO 和患者偏好信息,以实现深度患者表型分析并告知临床决策, 个性化治疗,以改善治疗效果。这项工作将涉及软件和硬件 开发,使数据收集,分析和可视化的临床设置。技术开发 将与Switchbox Inc.合作开展这项工作。(软件战略)和优先设计公司。(监管 战略)。UH 2阶段的具体目标是:1)开发数字健康平台,用于收集,分析, 并报告核心cLBP指标; 2)进行可行性研究,以测试临床可操作性、可用性和实用性 原型; UH 3阶段的具体目标是:1)优化数字健康平台以进行翻译 通过BACPAC用于临床研究; 2)验证数字健康平台识别cLBP的实用性 患者表型,并为个体患者的最佳治疗途径提供临床决策。 该项目的成果将是一个数字健康平台,其中的数据可支持监管提交, 临床应用。在这项工作结束时,我们将有一个经过验证的工具,用于整合临床研究 由BACPAC财团支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Safdar N. Khan其他文献

Is There a "Sex Effect" in 30-Day Outcomes After Elective Posterior Lumbar Fusions?
选择性腰椎后路融合术后 30 天的结果是否存在“性别效应”?
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2
  • 作者:
    A. Malik;Nikhil Jain;Elizabeth Yu;Jeffery D. Kim;Safdar N. Khan
  • 通讯作者:
    Safdar N. Khan
What Is the Quality of Surgical Care for Patients with Hip Fractures at Critical Access Hospitals?
关键医院的髋部骨折患者的手术护理质量如何?
  • DOI:
    10.1097/corr.0000000000001458
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    A. Malik;Janice M Bonsu;M. Roser;Safdar N. Khan;L. Phieffer;Thuan V Ly;Ryan K. Harrison;Carmen E. Quatman
  • 通讯作者:
    Carmen E. Quatman
Declining Trend in Anti-osteoporotic Treatment, Despite a Rise in DEXA Screening Following "Sentinel" Distal Radius Fractures.
尽管“前哨”桡骨远端骨折后 DEXA 筛查有所增加,但抗骨质疏松治疗呈下降趋势。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Malik;A. Gordon;Hisham M. Awan;Safdar N. Khan;K. Goyal
  • 通讯作者:
    K. Goyal
Which patients are at risk for not receiving anti-osteoporosis treatment following hip fracture?: An ACS NSQIP analysis.
哪些患者在髋部骨折后有不接受抗骨质疏松治疗的风险?:ACS NSQIP 分析。
Volume-outcome relationships in spine surgery – does increasing caseload co-relate with reduced complications?
脊柱手术中的手术量与结果的关系——病例量的增加与并发症的减少是否相关?
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Malik;Safdar N. Khan
  • 通讯作者:
    Safdar N. Khan

Safdar N. Khan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Safdar N. Khan', 18)}}的其他基金

The Spine Phenome Project: Enabling Technology for Personalized Medicine
脊柱表型组项目:个性化医疗的支持技术
  • 批准号:
    9898031
  • 财政年份:
    2019
  • 资助金额:
    $ 307.49万
  • 项目类别:
An automated AI/ML platform for multi-researcher collaborations for a NIH BACPAC funded Spine Phenome Project
用于 NIH BACPAC 资助的脊柱表型项目的多研究人员协作的自动化 AI/ML 平台
  • 批准号:
    10594295
  • 财政年份:
    2019
  • 资助金额:
    $ 307.49万
  • 项目类别:
The Spine Phenome Project: Enhancing Patient Diversity
脊柱表型组项目:增强患者多样性
  • 批准号:
    10616220
  • 财政年份:
    2019
  • 资助金额:
    $ 307.49万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 307.49万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 307.49万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 307.49万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了